1. Home
  2. KTTA vs OUSTW Comparison

KTTA vs OUSTW Comparison

Compare KTTA & OUSTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KTTA
  • OUSTW
  • Stock Information
  • Founded
  • KTTA 2020
  • OUSTW N/A
  • Country
  • KTTA United States
  • OUSTW United States
  • Employees
  • KTTA N/A
  • OUSTW N/A
  • Industry
  • KTTA Biotechnology: Pharmaceutical Preparations
  • OUSTW Industrial Machinery/Components
  • Sector
  • KTTA Health Care
  • OUSTW Industrials
  • Exchange
  • KTTA Nasdaq
  • OUSTW Nasdaq
  • Market Cap
  • KTTA 3.2M
  • OUSTW 3.1M
  • IPO Year
  • KTTA 2021
  • OUSTW N/A
  • Fundamental
  • Price
  • KTTA $2.48
  • OUSTW $0.05
  • Analyst Decision
  • KTTA
  • OUSTW
  • Analyst Count
  • KTTA 0
  • OUSTW 0
  • Target Price
  • KTTA N/A
  • OUSTW N/A
  • AVG Volume (30 Days)
  • KTTA 43.9K
  • OUSTW N/A
  • Earning Date
  • KTTA 11-13-2024
  • OUSTW N/A
  • Dividend Yield
  • KTTA N/A
  • OUSTW N/A
  • EPS Growth
  • KTTA N/A
  • OUSTW N/A
  • EPS
  • KTTA N/A
  • OUSTW N/A
  • Revenue
  • KTTA N/A
  • OUSTW N/A
  • Revenue This Year
  • KTTA N/A
  • OUSTW N/A
  • Revenue Next Year
  • KTTA N/A
  • OUSTW N/A
  • P/E Ratio
  • KTTA N/A
  • OUSTW N/A
  • Revenue Growth
  • KTTA N/A
  • OUSTW N/A
  • 52 Week Low
  • KTTA $2.20
  • OUSTW N/A
  • 52 Week High
  • KTTA $9.25
  • OUSTW N/A
  • Technical
  • Relative Strength Index (RSI)
  • KTTA 38.84
  • OUSTW N/A
  • Support Level
  • KTTA $2.20
  • OUSTW N/A
  • Resistance Level
  • KTTA $2.61
  • OUSTW N/A
  • Average True Range (ATR)
  • KTTA 0.28
  • OUSTW 0.00
  • MACD
  • KTTA -0.03
  • OUSTW 0.00
  • Stochastic Oscillator
  • KTTA 24.35
  • OUSTW 0.00

About KTTA Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia.

Share on Social Networks: